After the COVID-19 pandemic put unprecedented financial pressure on clinical laboratories and in vitro diagnostics (IVD) companies, these specific companies received $5.3 billion in capital alone in 2020. Will that level of investment remain? And what happens going forward?

Molecular diagnostic methods, including next-generation sequencing (NGS)-based tests, have undergone explosive growth in the last decade and play an increasingly important role in clinical microbiology laboratories. Despite the incredible promise of NGS-based tests for infectious diseases, the question remains whether we are able to overcome significant hurdles to make this…

A new guidance document on laboratory investigation of acute kidney injury (AKI) released by the AACC Academy aims to better guide clinicians and laboratorians in their evaluations of AKI, with the goal of promoting best practices to improve patient outcomes.

September’s Ask the Expert explores clinical management of antiepileptic drug levels for therapeutic drug monitoring.

To boost efficiency with urinalysis, many laboratories have implemented reflex testing approaches. If paired with carefully designed electronic order options and clinical decision-support systems, this strategy has the potential to optimize test utilization, improve result turnaround times, and reduce laboratory costs for reagents and labor.

A newly developed at-home fertility test, Inito, has launched on the U.S. market. The test aims to help users better understand hormone and ovulation information.

After December 31, 2021, the Centers for Disease Control and Prevention (CDC) will withdraw its request to the Food and Drug Administration for emergency use authorization of the CDC 2019-Novel Coronavirus Real-Time RT-PCR diagnostic panel.

CLN September’s Special Supplement highlights five interdisciplinary teams chosen by Abbott and other leading healthcare organizations for the UNIVANTS of Healthcare Excellence program for quality, patient-focused achievements.